Genus Capital Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-40,236
Closed -$6.7M 313
2024
Q4
$6.7M Buy
40,236
+2,490
+7% +$442K 0.91% 35
2024
Q3
$6.43M Buy
+37,746
New +$5.47M 0.84% 41

Other funds holding ORCL

Genus Capital Management's ORCL Position: Q1 2026 in Review

Genus Capital Management sold out of Oracle (ORCL) in Q1 2026, closing a stake of 1,088 shares — an estimated $212K sold.

Genus Capital Management first reported a position in ORCL in Q2 2023 and held it in 6 quarters. The position peaked at $11.1M in Q3 2023. 3,476 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Genus Capital Management reported no remaining Oracle position as of Q1 2026 after selling out during the quarter.
  • Genus Capital Management sold 1,088 Oracle shares in Q1 2026, an estimated $212K.
  • Genus Capital Management first reported a position in Oracle in Q2 2023 and held it in 6 quarters.
  • Genus Capital Management's Oracle position peaked at $11.1M in Q3 2023.
  • 3,476 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Genus Capital Management's 13F filing for Q1 2026, filed 4 May 2026.